Antitumor activity and mechanisms of dual EGFR/DNA-targeting strategy for the treatment of lung cancer with EGFRL858R/T790M mutation
Lumei Dai, Feng Qin, Yuying Xie, Bin Zhang, Zhijie Zhang, Sijia Liang, Fujia Chen, Xiaochao Huang, Heng‐Shan Wang
Topics & Concepts
T790MChemistryGefitinibEGFR inhibitorsEpidermal growth factor receptorDocking (animal)DNA damageGrowth inhibitionIC50In vitroPharmacologyCancer researchBiochemistryDNAReceptorBiologyMedicineNursingCancer therapeutics and mechanismsLung Cancer Treatments and MutationsQuinazolinone synthesis and applications